NCT00174603View on ClinicalTrials.gov

Treatment of Depression With Quetiapine

PHASE3TerminatedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

January 31, 2007

Conditions

Major Depression With Psychotic Features

Interventions

DRUG

quetiapine

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Rush University Medical Center

OTHER